New Risk Score Assesses Stroke Risk After MI Without A-Fib

Share this content:
New Risk Score Assesses Stroke Risk After MI Without A-Fib
New Risk Score Assesses Stroke Risk After MI Without A-Fib

WEDNESDAY, Feb. 28, 2018 (HealthDay News) -- A new risk score incorporates readily accessible risk factors associated with the occurrence of stroke in patients after myocardial infarction (MI) in the absence of atrial fibrillation (AF), according to a study published in the Feb. 20 issue of the Journal of the American College of Cardiology.

João Pedro Ferreira, M.D., Ph.D., from the University of Lorraine in France, and colleagues pooled data from four trials (22,904 patients) to identify risk factors (excluding AF) for the occurrence of stroke and to develop a calibrated and validated stroke risk score in patients with MI and heart failure and/or systolic dysfunction.

The researchers found that over a median 1.9 years of follow-up, 660 patients (2.9 percent) had a stroke. These patients were older and more often female, smokers, and hypertensive. In addition, stroke patients had a higher Killip class; a lower estimated glomerular filtration rate; and a higher proportion of histories of MI, heart failure, diabetes, and stroke. The final stroke risk model included older age, Killip class 3 or 4, estimated glomerular filtration rate ≤45 ml/min/1.73 m², hypertension history, and previous stroke. The models showed moderate to good discrimination and were well-calibrated. The observed three-year event rates increased steeply for each sextile of the stroke risk score (1.8, 2.9, 4.1, 5.6, 8.3, and 10.9 percent, respectively) and were in agreement with the expected event rates.

"This score may help in the identification of patients with MI and heart failure and a high risk for stroke despite their not presenting with AF," the authors write.

Several authors disclosed financial ties to the pharmaceutical industry.

Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »